Fevzi Sarper Türker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fevzi Sarper Türker has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ayşe Doğan
EGE ÜNİVERSİTESİ, FEN BİLİMLERİ ENSTİTÜSÜ, BİYOMEDİKAL TEKNOLOJİLER ANABİLİM DALI (DİSİPLİNLERARASI)
2 shared publications Davut Azboy
2 shared publicationsMine Erişir
2 shared publicationsZeki Temiztürk
2 shared publicationsAyse Malbora
Bitlis Eren Univ, Hlth High Sch, Dept Physiotherapy & Rehabil, Bitlis, Turkey
1 shared publication- Aysel Türkvatan
Department of Radiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, İstanbul, Türkiye
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (3) , 252-262
Cardiac magnetic resonance imaging assessment of Del Nido versus cold blood cardioplegia in patients with low ejection fraction undergoing combined coronary artery bypass graft and mitral valve replacement: Early outcomes
This study aimed to compare the effects of Del Nido cardioplegia (DNC) and conventional cold blood cardioplegia (CBC) on early myocardial functional recovery, as assessed by cardiac magnetic resonance imaging, in patients with reduced ejection fraction undergoing concomitant coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). This single-center prospective study was conducted between April 2024 and January 2025 and included 42 patients with a left ventricular ejection fraction (LVEF) <45% who underwent concomitant CABG and MVR. The mean age was 62.2±10.6 years, and 69.0% (n=29) of the patients were male. Patients were divided into two groups according to the myocardial protection strategy used: CBC (n=23) and DNC (n=19). Preoperative demographic, laboratory, and echocardiographic data were collected, and CMR was performed approximately 1 week before surgery to establish baseline values. Intraoperative parameters, postoperative clinical, laboratory, and echocardiographic findings as well as follow-up CMR findings obtained 1 month postoperatively were analyzed and compared between the groups. The aortic cross-clamp time was significantly longer in the DNC group than in the CBC group (p=0.016), whereas the total volume of infused cardioplegia was comparable between the groups (p=0.323). Intraoperative blood transfusion requirements were significantly higher in the DNC group (p=0.013). Regarding myocardial recovery, the DNC group demonstrated superior biventricular improvement. Significant reductions in left ventricular end-diastolic volume (p<0.001) and end-systolic volume (p<0.001) indicated pronounced reverse remodeling and were accompanied by a modest increase in LVEF (p=0.046). Similarly, postoperative right ventricular (RV) function was significantly better in the DNC group (p=0.026), with a significant decrease in the RV end-systolic volume index (p=0.025), reflecting improved systolic emptying. Although in-hospital mortality was numerically higher in the DNC group (31.6% vs. 8.7%), the difference was not statistically significant (p=0.112). Importantly, all deaths were associated with refractory low cardiac output syndrome during the postoperative intensive care unit stay. CMR findings suggest that DNC may be a safe and effective myocardial protection strategy in patients with reduced LVEF undergoing CABG and MVR. Furthermore, DNC appeared superior to CBC in promoting early biventricular reverse remodeling in this study population. The higher mortality observed in the DNC group may be attributable to the small sample size, longer cross-clamp times, greater operative complexity, and potential selection bias.
- 1 July 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (3) , 252-262
Open AccessCardiac magnetic resonance imaging assessment of Del Nido versus cold blood cardioplegia in patients with low ejection fraction undergoing combined coronary artery bypass graft and mitral valve replacement: Early outcomes
This study aimed to compare the effects of Del Nido cardioplegia (DNC) and conventional cold blood cardioplegia (CBC) on early myocardial functional recovery, as assessed by cardiac magnetic resonance imaging, in patients with reduced ejection fraction undergoing concomitant coronary artery bypass grafting (CABG) and mitral valve replacement (MVR). This single-center prospective study was conducted between April 2024 and January 2025 and included 42 patients with a left ventricular ejection fraction (LVEF) <45% who underwent concomitant CABG and MVR. The mean age was 62.2±10.6 years, and 69.0% (n=29) of the patients were male. Patients were divided into two groups according to the myocardial protection strategy used: CBC (n=23) and DNC (n=19). Preoperative demographic, laboratory, and echocardiographic data were collected, and CMR was performed approximately 1 week before surgery to establish baseline values. Intraoperative parameters, postoperative clinical, laboratory, and echocardiographic findings as well as follow-up CMR findings obtained 1 month postoperatively were analyzed and compared between the groups. The aortic cross-clamp time was significantly longer in the DNC group than in the CBC group (p=0.016), whereas the total volume of infused cardioplegia was comparable between the groups (p=0.323). Intraoperative blood transfusion requirements were significantly higher in the DNC group (p=0.013). Regarding myocardial recovery, the DNC group demonstrated superior biventricular improvement. Significant reductions in left ventricular end-diastolic volume (p<0.001) and end-systolic volume (p<0.001) indicated pronounced reverse remodeling and were accompanied by a modest increase in LVEF (p=0.046). Similarly, postoperative right ventricular (RV) function was significantly better in the DNC group (p=0.026), with a significant decrease in the RV end-systolic volume index (p=0.025), reflecting improved systolic emptying. Although in-hospital mortality was numerically higher in the DNC group (31.6% vs. 8.7%), the difference was not statistically significant (p=0.112). Importantly, all deaths were associated with refractory low cardiac output syndrome during the postoperative intensive care unit stay. CMR findings suggest that DNC may be a safe and effective myocardial protection strategy in patients with reduced LVEF undergoing CABG and MVR. Furthermore, DNC appeared superior to CBC in promoting early biventricular reverse remodeling in this study population. The higher mortality observed in the DNC group may be attributable to the small sample size, longer cross-clamp times, greater operative complexity, and potential selection bias.
- Open Access
- 29 March 2023
- Published by IntechOpen
Tricuspid Valve Repair
For the previous years, the tricuspid valve (TV), has been studied relatively less than the other heart valves diseases both about pathophysiology, management, surgical intervention, and treatment. However, recent advances in assessment and management of the TV disease have led to redirect the interest in this “forgotten valve.” Surgeons often had believed that quick solutions for the left ventricle problems would also improve the secondary tricuspid regurgitation (STR). Every active surgeon has been preferred this quick solution in his whole surgery life many times. Medical treatment options aims to improve the underlying disease and the right ventricle failure. TV surgery have proven to yield good outcomes in surgery indicated patients. For patients who are not available for surgery, trans catheter intervention may be an alternative. Due to limited data, the best surgical techniques are still in question, with no clear answer, particularly for STR. Key factor in determining prognosis, timing for intervention and longer-term outcome is the right ventricular function at the time of prognosis.
- 29 March 2023
- Published by IntechOpen
Open AccessTricuspid Valve Repair
For the previous years, the tricuspid valve (TV), has been studied relatively less than the other heart valves diseases both about pathophysiology, management, surgical intervention, and treatment. However, recent advances in assessment and management of the TV disease have led to redirect the interest in this “forgotten valve.” Surgeons often had believed that quick solutions for the left ventricle problems would also improve the secondary tricuspid regurgitation (STR). Every active surgeon has been preferred this quick solution in his whole surgery life many times. Medical treatment options aims to improve the underlying disease and the right ventricle failure. TV surgery have proven to yield good outcomes in surgery indicated patients. For patients who are not available for surgery, trans catheter intervention may be an alternative. Due to limited data, the best surgical techniques are still in question, with no clear answer, particularly for STR. Key factor in determining prognosis, timing for intervention and longer-term outcome is the right ventricular function at the time of prognosis.
- Open Access
- 28 December 2021
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2021, 1-8
Procedure and Clinical Success of Drug-Coated Balloon Fistuloplasty of the Drainage Vein in Dysfunctional Native Arteriovenous Fistulas
Purpose. Native arteriovenous fistulas (AVFs) are the most effective vascular access (VA) for haemodialysis. We aimed to evaluate the results of balloon angioplasty (fistuloplasty) from drainage vein performed for the treatment of AVF dysfunction in haemodialysis patients and examine potential patient and AVF-associated factors that might affect such results. Methods. This is a nonrandomized, retrospective, and single-centred study. A total of 105 balloon fistuloplasties were performed for dysfunctional AVFs of 82 haemodialysis patients. Patients were treated with a drug-coated balloon according to standard procedures. Evaluations were performed by physical examinations and if needed by color Doppler imaging in every 6 months. The primary endpoint was patency by balloon fistuloplasty. Patency was evaluated clinically by detecting the thrill in AVF and by the adequacy of the dialysis. Multidimensional scaling (MDS) technique was used as a method for the statistical analysis. Results. The success of the procedure after the first attempt was 85.3 with 70 patients. Patency in the 6th, 12th, 18th, and 24th months were 63 (76.8), 60 (73.1), 53 (64.6), and 44 (54), respectively. The procedure was considered successful when the thrill was detected in AVF and when dialysis was adequate. The statistical analysis by MDS revealed that patients age was the most effective factor acting on the procedure success followed by the age of AVF. Other patient-associated and AVF-associated factors were not found as effective statistical evaluation. Conclusions. Haemodialysis through native AVFs with restored functionality contributes positively to the life span and the quality of life of the patient. Probably, advanced age and high fistula age are unfavourable factors leading to the development of neointimal hyperplasia and venous stenosis. Balloon fistuloplasty of the draining vein is an effective and safe method regardless of patient age and the age of AVF.
- 28 December 2021
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2021, 1-8
Open AccessProcedure and Clinical Success of Drug-Coated Balloon Fistuloplasty of the Drainage Vein in Dysfunctional Native Arteriovenous Fistulas
Purpose. Native arteriovenous fistulas (AVFs) are the most effective vascular access (VA) for haemodialysis. We aimed to evaluate the results of balloon angioplasty (fistuloplasty) from drainage vein performed for the treatment of AVF dysfunction in haemodialysis patients and examine potential patient and AVF-associated factors that might affect such results. Methods. This is a nonrandomized, retrospective, and single-centred study. A total of 105 balloon fistuloplasties were performed for dysfunctional AVFs of 82 haemodialysis patients. Patients were treated with a drug-coated balloon according to standard procedures. Evaluations were performed by physical examinations and if needed by color Doppler imaging in every 6 months. The primary endpoint was patency by balloon fistuloplasty. Patency was evaluated clinically by detecting the thrill in AVF and by the adequacy of the dialysis. Multidimensional scaling (MDS) technique was used as a method for the statistical analysis. Results. The success of the procedure after the first attempt was 85.3 with 70 patients. Patency in the 6th, 12th, 18th, and 24th months were 63 (76.8), 60 (73.1), 53 (64.6), and 44 (54), respectively. The procedure was considered successful when the thrill was detected in AVF and when dialysis was adequate. The statistical analysis by MDS revealed that patients age was the most effective factor acting on the procedure success followed by the age of AVF. Other patient-associated and AVF-associated factors were not found as effective statistical evaluation. Conclusions. Haemodialysis through native AVFs with restored functionality contributes positively to the life span and the quality of life of the patient. Probably, advanced age and high fistula age are unfavourable factors leading to the development of neointimal hyperplasia and venous stenosis. Balloon fistuloplasty of the draining vein is an effective and safe method regardless of patient age and the age of AVF.
- 27 December 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 56 (3) , 253-257
Bacterial Load Associated With Tunneled Dialysis Catheters in Symptom-Free Hemodialysis Patients
This study aimed to evaluate the rate of asymptomatic bacterial infection of tunneled dialysis catheters (TDCs) removed due to maturation of native arteriovenous fistula (nAVF) or catheter dysfunction in hemodialysis patients with no clinically apparent infection. A total of 229 patients (43.2% [n = 99] female and 56.8% [n = 130] male), who underwent hemodialysis through a TDC, were included in this study. Tip cultures of TDCs removed in an operating room and under sterile conditions were collected. All patients were asymptomatic for catheter infection and had not received antibiotic therapy for the last month. The median duration of catheterization was 80 days (min: 5, max: 2880). Bacterial growth was observed in a total of 62 (27.1%) patients. The most common microorganisms were Staphylococcus epidermidis and Staphylococcus aureus. The asymptomatic infection rate was highest in catheters placed through the right and left subclavian veins; however, this was not statistically significant due to the small number of patients. Placement and usage time of TDCs were found to be the most significant factors for bacterial growth in the catheter tip culture (P < .001). Prolonged duration and use of the catheter is significant in terms of bacterial load. The use of TDC as vascular access in renal replacement therapy should be avoided as much as possible.
- 27 December 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 56 (3) , 253-257
Bacterial Load Associated With Tunneled Dialysis Catheters in Symptom-Free Hemodialysis Patients
This study aimed to evaluate the rate of asymptomatic bacterial infection of tunneled dialysis catheters (TDCs) removed due to maturation of native arteriovenous fistula (nAVF) or catheter dysfunction in hemodialysis patients with no clinically apparent infection. A total of 229 patients (43.2% [n = 99] female and 56.8% [n = 130] male), who underwent hemodialysis through a TDC, were included in this study. Tip cultures of TDCs removed in an operating room and under sterile conditions were collected. All patients were asymptomatic for catheter infection and had not received antibiotic therapy for the last month. The median duration of catheterization was 80 days (min: 5, max: 2880). Bacterial growth was observed in a total of 62 (27.1%) patients. The most common microorganisms were Staphylococcus epidermidis and Staphylococcus aureus. The asymptomatic infection rate was highest in catheters placed through the right and left subclavian veins; however, this was not statistically significant due to the small number of patients. Placement and usage time of TDCs were found to be the most significant factors for bacterial growth in the catheter tip culture (P < .001). Prolonged duration and use of the catheter is significant in terms of bacterial load. The use of TDC as vascular access in renal replacement therapy should be avoided as much as possible.
- 1 January 2021
- Vol. 11 (1) , 176-183
Oxidative status and antioxidant enzyme levels in deep venous thrombosis patients
Deep vein thrombosis (DVT), a subset of venous thromboembolism (VTE), is a major preventable cause of morbidity and mortality worldwide. We aim to investigate changes in oxidative injury markers and the levels of antioxidant parameters in DVT patients. 50 DVT patients who were admitted to the cardiovascular surgery clinic with acute (= 4 weeks) DVT and 100 healthy individuals were included. As oxidative injury marker malondialdehyde and the antioxidant parameters including reduced glutathione, glutathione peroxidase, catalase, and superoxide dismutase were analysed in the collected peripheral blood samples. Demographic characteristics of the acute and chronic DVT patients were similar (P>0.05). In all DVT patients having thrombosis in the distal and proximal leg veins the mean malondialdehyde and glutathione peroxidase activity were significantly increased, but superoxide dismutase activity significantly decreased, compared to the healthy controls (P<0.05). No difference was observed between distal and proximal DVT patient groups. The increased levels of malondialdehyde in our study is considered to result from the significant decrease in the antioxidant enzyme activity of superoxide dismutase. Furthermore, we are of the opinion that the increased levels of glutathione peroxidase enzyme activity observed in all patients could not compensate the reduction in the superoxide dismutase activity, thereby being insufficient in preventing the increase in the malondialdehyde levels.
- 1 January 2021
- Vol. 11 (1) , 176-183
Oxidative status and antioxidant enzyme levels in deep venous thrombosis patients
Deep vein thrombosis (DVT), a subset of venous thromboembolism (VTE), is a major preventable cause of morbidity and mortality worldwide. We aim to investigate changes in oxidative injury markers and the levels of antioxidant parameters in DVT patients. 50 DVT patients who were admitted to the cardiovascular surgery clinic with acute (= 4 weeks) DVT and 100 healthy individuals were included. As oxidative injury marker malondialdehyde and the antioxidant parameters including reduced glutathione, glutathione peroxidase, catalase, and superoxide dismutase were analysed in the collected peripheral blood samples. Demographic characteristics of the acute and chronic DVT patients were similar (P>0.05). In all DVT patients having thrombosis in the distal and proximal leg veins the mean malondialdehyde and glutathione peroxidase activity were significantly increased, but superoxide dismutase activity significantly decreased, compared to the healthy controls (P<0.05). No difference was observed between distal and proximal DVT patient groups. The increased levels of malondialdehyde in our study is considered to result from the significant decrease in the antioxidant enzyme activity of superoxide dismutase. Furthermore, we are of the opinion that the increased levels of glutathione peroxidase enzyme activity observed in all patients could not compensate the reduction in the superoxide dismutase activity, thereby being insufficient in preventing the increase in the malondialdehyde levels.
- Open Access
- 25 June 2020
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 29 (3) , 189-195
The effect of deep venous thrombosis on oxidative damage and vitamin A and beta-carotene levels
- 25 June 2020
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 29 (3) , 189-195
Open AccessThe effect of deep venous thrombosis on oxidative damage and vitamin A and beta-carotene levels
- Open Access
- 24 June 2020
- Published by IntechOpen
Hemorrhagic Shock
Hemorrhagic shock is a type of hypovolemic shock, where intravascular blood loss and consequent alterations in the cell due to the hypoxia result in tissue and organ dysfunction, leading to death, once a certain threshold level is exceeded. Inadequate oxygen delivery results with Na/K ATPase pump dysfunction and cell death by this way, but erythrocytes do not use oxygen for their survival. A depolarizing protein can be a reason under in vivo conditions. In severe injury, rapid loss of 25% and more blood volume cause irreversible shock. For blood restoration, crystalloid solutions temporarily provide a practical approach, but they cannot replace the lost erythrocyte mass occurred due to bleeding, and they have no therapeutic value. Excessive use causes several problems, especially coagulopathy and increases the mortality risk. The prompt transfer of patient to an ultimate center for treatment, use of blood and blood products in the treatment, and a swift restoration of hemorrhage source are essential. Tourniquet use in the extremities and balloon occlusion of the aorta can be lifesaving.
- 24 June 2020
- Published by IntechOpen
Open AccessHemorrhagic Shock
Hemorrhagic shock is a type of hypovolemic shock, where intravascular blood loss and consequent alterations in the cell due to the hypoxia result in tissue and organ dysfunction, leading to death, once a certain threshold level is exceeded. Inadequate oxygen delivery results with Na/K ATPase pump dysfunction and cell death by this way, but erythrocytes do not use oxygen for their survival. A depolarizing protein can be a reason under in vivo conditions. In severe injury, rapid loss of 25% and more blood volume cause irreversible shock. For blood restoration, crystalloid solutions temporarily provide a practical approach, but they cannot replace the lost erythrocyte mass occurred due to bleeding, and they have no therapeutic value. Excessive use causes several problems, especially coagulopathy and increases the mortality risk. The prompt transfer of patient to an ultimate center for treatment, use of blood and blood products in the treatment, and a swift restoration of hemorrhage source are essential. Tourniquet use in the extremities and balloon occlusion of the aorta can be lifesaving.
- Open Access
- 11 December 2019
- Published by IntechOpen
Hemostasis in Cardiac Surgery: How We Do it with Limited Resources
Hemostasis in cardiac surgery is still a severe problem for surgeons. Blood and its products are the most valuable at the same time dangerous arms of surgeons. Industries produced many biological or non-biological products, which increase the cost of operations, are available for this issue. Decision making and producing solutions must be the most important properties of a cardiac surgeon. In any condition and resources, true strategy and patience will bring the success. Antiaggregants and anticoagulants are widely used agents, and in emergency or early cases, surgeons have to operate these patients. Both groups of drugs are growing, and in an emergency position, it is hard to know which drugs the patient using or given and what kind of medical status he/she has. For example non vitamin-K oral anticoagulants newer drugs and not known so much except cardiologists and cardiovascular surgeons. Simple solutions may have better results. Of course, in some conditions, urgent consultation can solve the problem. Cardiac surgeons have to figure out the problem by using their experience and surgical materials. Working as a team is a big advantage, more than one surgeon, experienced operation nurses and closer follow up in intensive care unit.
- 11 December 2019
- Published by IntechOpen
Open AccessHemostasis in Cardiac Surgery: How We Do it with Limited Resources
Hemostasis in cardiac surgery is still a severe problem for surgeons. Blood and its products are the most valuable at the same time dangerous arms of surgeons. Industries produced many biological or non-biological products, which increase the cost of operations, are available for this issue. Decision making and producing solutions must be the most important properties of a cardiac surgeon. In any condition and resources, true strategy and patience will bring the success. Antiaggregants and anticoagulants are widely used agents, and in emergency or early cases, surgeons have to operate these patients. Both groups of drugs are growing, and in an emergency position, it is hard to know which drugs the patient using or given and what kind of medical status he/she has. For example non vitamin-K oral anticoagulants newer drugs and not known so much except cardiologists and cardiovascular surgeons. Simple solutions may have better results. Of course, in some conditions, urgent consultation can solve the problem. Cardiac surgeons have to figure out the problem by using their experience and surgical materials. Working as a team is a big advantage, more than one surgeon, experienced operation nurses and closer follow up in intensive care unit.
- Open Access
- 9 October 2019
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 28 (3) , 151-158
Evaluation of oxidative and antioxidant markers in the blood samples of patients with abdominal aorta pathology
Objectives: This study aims to investigate the effects of oxidative damage on the development of the disease in patients scheduled for surgery for aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Patients and methods: Between June 2015 and July 2016, a total of 24 patients (22 males, 2 females; mean age 63.2±10.4 years; range, 41 to 76 years) who admitted to our clinic for surgery were included in the study. The study group consisted of all elective AOD and AAA patients. The control group (n=100) consisted of healthy volunteers including health care personnel, particularly physicians working in the hospital. We obtained blood samples before surgery and compared levels of malondialdehyde (MDA) as an indicator of oxidative damage, and the levels of certain antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH) with the blood levels of healthy volunteers. Results: The comparison of the patient and healthy volunteer groups showed that blood MDA levels increased due to the oxidative damage (p=0.001). Regarding the antioxidant activity, we found that GSH levels increased in the patient group; however, the SOD activity remained unchanged. The CAT activity was statistically significantly decreased in the patient group (p=0.001). Conclusion: The increased oxidative damage levels (MDA) in all patient groups compared to healthy individuals may indicate that oxidative stress has an important role in the development of the disease. In the light of these results, we conclude that the GSH activity is not sufficient to compensate the existing damage and the low CAT activity in all groups may show that it has a role in the development of the disease.
- 9 October 2019
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 28 (3) , 151-158
Open AccessEvaluation of oxidative and antioxidant markers in the blood samples of patients with abdominal aorta pathology
Objectives: This study aims to investigate the effects of oxidative damage on the development of the disease in patients scheduled for surgery for aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Patients and methods: Between June 2015 and July 2016, a total of 24 patients (22 males, 2 females; mean age 63.2±10.4 years; range, 41 to 76 years) who admitted to our clinic for surgery were included in the study. The study group consisted of all elective AOD and AAA patients. The control group (n=100) consisted of healthy volunteers including health care personnel, particularly physicians working in the hospital. We obtained blood samples before surgery and compared levels of malondialdehyde (MDA) as an indicator of oxidative damage, and the levels of certain antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH) with the blood levels of healthy volunteers. Results: The comparison of the patient and healthy volunteer groups showed that blood MDA levels increased due to the oxidative damage (p=0.001). Regarding the antioxidant activity, we found that GSH levels increased in the patient group; however, the SOD activity remained unchanged. The CAT activity was statistically significantly decreased in the patient group (p=0.001). Conclusion: The increased oxidative damage levels (MDA) in all patient groups compared to healthy individuals may indicate that oxidative stress has an important role in the development of the disease. In the light of these results, we conclude that the GSH activity is not sufficient to compensate the existing damage and the low CAT activity in all groups may show that it has a role in the development of the disease.
- Open Access
- 10 January 2019
- Published by IntechOpen
Cardiogenic Shock
Cardiogenic shock (CS) is an end-organ hypoperfusion associated with heart failure. Any reason impairing acute left ventricular (LV) or right ventricular (RV) function may cause CS. The only way to avoid CS is to provide early reperfusion in myocardial infarction (MI) patients. CS is characterized by permanent or transient rearrangement of the entire circulatory system. According to the current IABP-SHOCK II trial, 74% of the patients with CSMI are treated with norepinephrine, 53% of them with dobutamine, 26% of them with epinephrine, 4% of them with levosimendan, and 4% of them with dopamine. Percutaneous circulatory support devices such as intra-aortic balloon pump (IABP), LV assist device (LVAD), or extracorporeal life support (ECLS) create treatment options for selected patients such as CS, cardiopulmonary resuscitation, or high-risk pPCI and CABG. Extracorporeal Life Support Organization (ELSO, 2017) evaluated that the use of ECLS/VA-ECMO should be considered when the mortality risk exceeds 50% despite optimal conventional treatment in case of acute severe heart or pulmonary failure, whereas it should be assessed as a primary indication when it exceeds 80%. Early and effective revascularization is the best treatment option for CS. Thus, the organizations on the national and global basis will play the most effective role for the short- and long-term survival of patients.
- 10 January 2019
- Published by IntechOpen
Open AccessCardiogenic Shock
Cardiogenic shock (CS) is an end-organ hypoperfusion associated with heart failure. Any reason impairing acute left ventricular (LV) or right ventricular (RV) function may cause CS. The only way to avoid CS is to provide early reperfusion in myocardial infarction (MI) patients. CS is characterized by permanent or transient rearrangement of the entire circulatory system. According to the current IABP-SHOCK II trial, 74% of the patients with CSMI are treated with norepinephrine, 53% of them with dobutamine, 26% of them with epinephrine, 4% of them with levosimendan, and 4% of them with dopamine. Percutaneous circulatory support devices such as intra-aortic balloon pump (IABP), LV assist device (LVAD), or extracorporeal life support (ECLS) create treatment options for selected patients such as CS, cardiopulmonary resuscitation, or high-risk pPCI and CABG. Extracorporeal Life Support Organization (ELSO, 2017) evaluated that the use of ECLS/VA-ECMO should be considered when the mortality risk exceeds 50% despite optimal conventional treatment in case of acute severe heart or pulmonary failure, whereas it should be assessed as a primary indication when it exceeds 80%. Early and effective revascularization is the best treatment option for CS. Thus, the organizations on the national and global basis will play the most effective role for the short- and long-term survival of patients.